RESUMO
This article reports a case of primary renal angiosarcoma, a very rare and aggressive malignancy, in a 59-year-old male patient. The mean overall survival time is limited to a few months if the diagnosis is made when clinical symptoms are present but chances of a cure can be increased with surgical resection of smaller incidental findings. Due to the lack of a standard therapy, systemic treatment is based on the therapy of other soft tissue sarcomas. The role of adjuvant medical treatment particularly in angiosarcoma remains poorly studied but using a doxorubicin-based chemotherapy regimen, a survival benefit can be achieved.
Assuntos
Hemangiossarcoma/patologia , Hemangiossarcoma/terapia , Neoplasias Renais/patologia , Neoplasias Renais/terapia , Antibióticos Antineoplásicos/uso terapêutico , Terapia Combinada/métodos , Doxorrubicina/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Nefrectomia/métodos , Doenças Raras/patologia , Doenças Raras/terapia , Resultado do TratamentoRESUMO
We describe the previously unknown case of segmental testicular infarction as an iatrogenic complication of intravenous immunoglobulin administration in a patient with multifocal motor neuropathy.